Termination of Trust Agreement Upon Completion of 632,137 Treasury Shares Acquisition
- REMED terminated its 2 billion won treasury share acquisition trust agreement (dated Feb 9, 2026) early on May 20, 2026, due to completion of share acquisition
- The 632,137 common shares (2.05% of total outstanding) acquired via the trust will be held as treasury shares in the company's account; no plan for disposal or cancellation has been decided
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Report on Major Matters (Decision on Termination of Trust Agreement for Acquisition of Treasury Shares)
- Company: REMED (302550)
- Submission: REMED CO.,LTD.
- Receipt: 05-20-2026